Cellular and molecular biology of the prostate: Stem cell biology

Urology

Volumn 62, Issue 5 SUPPL. 1, 2003, Pages 11-20

  Schalken, Jack A ^a   Van Leenders, Geert ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CELL MARKER; CHROMOGRANIN A; KERATIN; TESTOSTERONE; THYMIDINE;

APOPTOSIS; BASAL CELL; BASEMENT MEMBRANE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SUBPOPULATION; CELL TYPE; DEVELOPMENT; EPITHELIUM; HORMONE ACTION; HUMAN; HYPOTHESIS; IMMUNOPHENOTYPING; MALIGNANT TRANSFORMATION; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; STEM CELL; STROMA; TUMOR CELL;

EID: 0242691894     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00758-1     Document Type: Article

References (21)

1. Luo J., Duggan D.J., Chen Y., et al. Human prostate cancer and benign prostatic hyperplasia molecular dissection by gene expression profiling . Cancer Res. 61:2001;4683-4688.
2. Isaacs J.T., Coffey D.S. Etiology and disease process of benign prostatic hyperplasia. Prostate. 2:1989;33-50.
3. Xue Y., Smedts F., Umbas R., et al. Changes in keratin expression during the development of benign prostatic hyperplasia. Eur Urol. 32:1997;332-338.
4. van Leenders G., Dijkman H., Hulsbergen-van de Kaa C.A., et al. Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy. Lab Invest. 80:2000;1251-1258.
5. Xue Y., Smedts F., Debruyne F.M.J., et al. Identification of intermediate cell types by keratin expression in the developing human prostate. Prostate. 34:1998;292-301.
6. Xue Y., Verhofstad A., Lange W., et al. Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2 cell kinetic features of neuroendocrine cells in the human prostate . Am J Pathol. 151:1997;1759-1765.
7. Berges R.R., Vukanovic J., Epstein J.I., et al. Implication of cell kinetic changes during the progression of human prostatic cancer. Clin Cancer Res. 1:1995;473-480.
8. Xue Y., Sonke G., Schoots C., et al. Proliferative activity and branching morphogenesis in the human prostate a closer look at pre- and postnatal prostate growth . Prostate. 49:2001;132-139.
9. McNeal J.E. Origin and evolution of benign prostatic enlargement. Invest Urol. 15:1978;340-345.
10. McNeal J.E. Normal histology of the prostate. Am J Surg Pathol. 12:1988;619-633.
11. Xue Y., Smedts F., Ruijter E.T., et al. Branching activity in the human prostate a closer look at the structure of small glandular buds . Eur Urol. 39:2001;222-231.
12. Planz B., Wang Q., Kirley S.D., et al. Androgen responsiveness of stromal cells of the human prostate regulation of cell proliferation and keratinocyte growth factor by androgen . J Urol. 160:1998;1850-1855.
13. Verhoeven G., Swinnen J.V. Indirect mechanisms and cascades of androgen action. Mol Cell Endocrinol. 151:1999;205-212.
14. Niu Y., Xu Y., Bai J., et al. Proliferation and differentiation of prostatic stromal cells. BJU Int. 87:2001;386-393.
15. Gao J., Arnold J.T., Isaacs J.T. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. Cancer Res. 61:2001;5038-5044.
16. Joseph I.B.J.K., Nelson J.B., Denmeade S.R., et al. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin Cancer Res. 3:1997;2507-2511.
17. van Leenders G., van Balken B., Aalders T., et al. Intermediate cells in normal and malignant prostate epithelium express C-MET implications for prostate cancer invasion . Prostate. 51:2002;98-107.
18. Verhagen A.P.M., Ramaeckers F.C.S., Aalders T.W., et al. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res. 52:1992;6182-6187.
19. van Leenders G.J.L.H., Aalders T.W., Hulsbergen-van de Kaa C.A., et al. Expression of basal cell keratins in human prostate cancer metastases and cell lines. J Pathol. 195:2001;563-570.
20. Jongsma J., Oomen M.H., Noordzij M.A., et al. Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model. Am J Pathol. 154:1999;543-551.
21. Herynk M.H., Tsan R., Radinsky R., et al. Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin. Clin Exp Metastasis. 20:2003;291-300.